NOVO.B.DK

262.4

-0.27%↓

GMAB.DK

1,671.5

-0.98%↓

HLUNB.DK

42.16

-2.63%↓

ZEAL.DK

306.1

-5.26%↓

AMBUB.DK

62.65

-3.17%↓

NOVO.B.DK

262.4

-0.27%↓

GMAB.DK

1,671.5

-0.98%↓

HLUNB.DK

42.16

-2.63%↓

ZEAL.DK

306.1

-5.26%↓

AMBUB.DK

62.65

-3.17%↓

NOVO.B.DK

262.4

-0.27%↓

GMAB.DK

1,671.5

-0.98%↓

HLUNB.DK

42.16

-2.63%↓

ZEAL.DK

306.1

-5.26%↓

AMBUB.DK

62.65

-3.17%↓

NOVO.B.DK

262.4

-0.27%↓

GMAB.DK

1,671.5

-0.98%↓

HLUNB.DK

42.16

-2.63%↓

ZEAL.DK

306.1

-5.26%↓

AMBUB.DK

62.65

-3.17%↓

NOVO.B.DK

262.4

-0.27%↓

GMAB.DK

1,671.5

-0.98%↓

HLUNB.DK

42.16

-2.63%↓

ZEAL.DK

306.1

-5.26%↓

AMBUB.DK

62.65

-3.17%↓

Search

Coloplast A-S (Class B)

Deschisă

402.8 -0.71

Rezumat

Modificarea prețului

24h

Curent

Minim

402.1

Maxim

409.8

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.492

60.328

EPS

6.32

Randament dividend

5.28

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.28%

2.24%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-21B

98B

Deschiderea anterioară

403.51

Închiderea anterioară

402.8

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 apr. 2026, 23:33 UTC

Acțiuni populare

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

28 apr. 2026, 23:24 UTC

Câștiguri

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

28 apr. 2026, 23:15 UTC

Evenimente importante

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

28 apr. 2026, 22:46 UTC

Câștiguri

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

28 apr. 2026, 22:37 UTC

Câștiguri

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

28 apr. 2026, 22:15 UTC

Câștiguri
Evenimente importante

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

28 apr. 2026, 23:33 UTC

Market Talk
Evenimente importante

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

28 apr. 2026, 23:31 UTC

Câștiguri

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

28 apr. 2026, 23:31 UTC

Câștiguri

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

28 apr. 2026, 23:30 UTC

Câștiguri

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

28 apr. 2026, 23:30 UTC

Câștiguri

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

28 apr. 2026, 23:19 UTC

Market Talk
Câștiguri

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

28 apr. 2026, 23:09 UTC

Câștiguri

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

28 apr. 2026, 23:03 UTC

Market Talk

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

28 apr. 2026, 23:01 UTC

Evenimente importante

NIESR Sees One Rate Rise to 4% in Benign Scenario

28 apr. 2026, 23:01 UTC

Evenimente importante

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

28 apr. 2026, 23:01 UTC

Evenimente importante

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

28 apr. 2026, 23:01 UTC

Evenimente importante

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

28 apr. 2026, 23:01 UTC

Evenimente importante

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

28 apr. 2026, 22:51 UTC

Câștiguri

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 apr. 2026, 22:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 apr. 2026, 22:48 UTC

Market Talk

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

28 apr. 2026, 22:40 UTC

Market Talk
Evenimente importante

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

28 apr. 2026, 22:32 UTC

Câștiguri

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

28 apr. 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

Pernod Ricard and Brown-Forman End Deal Talks -- Update

28 apr. 2026, 22:22 UTC

Câștiguri

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

28 apr. 2026, 22:17 UTC

Market Talk

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

28 apr. 2026, 22:14 UTC

Câștiguri

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

28 apr. 2026, 22:14 UTC

Câștiguri

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

28 apr. 2026, 22:07 UTC

Market Talk
Evenimente importante

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat